Monday, 27 March 2017

LUPIN RECEIVES US FDA APPROVAL FOR NOVARTIS GENERIC

Lupin receives US FDA approval for Novartis generic

Tobramycin inhalation solution USP, 300 mg/5 ml, had sales of $133.6 million in the US as of December 2016, Lupin stated in a release about the development.


NEW DELHI: The United States Food and Drug Administration (US FDA) has granted Indian drug maker Lupin final approval to market a generic version of Swiss pharmaceutical giant Novartistobramycin inhalation solution‘Tobi’.

The drug is used to treat cystic fibrosis patients with P. aeruginosa.

Tobramycin inhalation solution USP, 300 mg/5 ml, had sales of $133.6 million in the US as of December 2016, Lupin stated in a release about the development.

Share prices of Lupin rose 1.58 per cent to close at Rs1,490 on the Bombay Stock Exchange on Thursday, while the benchmark Sensex ended 0.56 per cent higher.

Source : http://health.economictimes.indiatimes.com/news/pharma/lupin-receives-us-fda-approval-for-novartis-generic/57793282

For more updates follow srinivasulutirumalasetty.blogspot.com

Thank you for visiting my blog , Visit again for latest pharma updates

No comments:

Post a Comment